In addition to the discovery of NRP1 as a SARS-CoV-2 entry coreceptor along with ACE2, we have assembled the pathological roles of NRPs and their involvement in clinical diseases, particularly highlighting the participation of NRPs in cancer. The gene discussed is ACE2; the disease is cancer.